Important Notice regarding Dextenza and Klarity-C

Posted in Latest News on October 15, 2019.

During the September 27, 2019 Board of Optometry meeting, the Board approved Dextenza (dexamethasone ophthalmic insert) 0.4 mg and approved Klarity-C (cyclosporine) 0.1% for addition to Rule 64B13-18.002, Florida Administrative Code – Formulary of Topical Pharmaceutical Agents.

Important Note: At this time, Dextenza and Klarity-C cannot be prescribed by Certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and both may be prescribed by Certified Optometrists at that time.



More Latest News

Governor DeSantis declares State of Emergency for Subtropical Storm Nicole
November 7, 2022

On Monday, November 7, 2022, Governor Ron DeSantis declared a State of Emergency to prepare for Subtropical Storm Nicole. Continue reading


2021-2022 Annual Report and Long-Range Plan Released 
October 31, 2022

The Annual Report and Long-Range Plan for Fiscal Year 2021-22 has been published. Click here for more information. Continue reading